EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Role of retinal biomarkers in diabetes detection and risk prediction: A systematic scoping review

Soujanya Kaup, Sowrabha Bhat, Erin E Reardon, Vijayaraghavan Prathiba, Ramachandran Rajalakshmi, Rodrigo M Carrillo-Larco, Ram Jagannathan, Ranjit Mohan Anjana, Mohammed K Ali, Viswanathan Mohan, Sudeshna Sil Kar, Anant Madabhushi und 2 weitere

Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2026-04 · 20 (4) · 103405

DOI: 10.1016/j.dsx.2026.103405 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2026-04. Verfasst von Soujanya Kaup und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Yenepoya (Deemed to be) University, Mangalore, India; Faculty of Epidemiology and Population Health, London School of Hy…. Hauptthemen laut MEDLINE: Biomarkers, Diabetes Mellitus, Type 2, Diabetic Retinopathy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, BLRD VA, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This systematic scoping review was conducted to map and synthesize literature on retinal biomarkers associated with type 2 diabetes (T2D), including conventional and Artificial Intelligence(AI)-derived features, while considering ethnic/geographic diversity. METHODS: Following PRISMA-ScR statement, seven databases were searched up to January 28, 2026 for cross-sectional and longitudinal studies in adults (≥18 years) with or without T2D. Included studies required a normoglycemic comparator and quantitative retinal assessment, with or without AI. Two reviewers independently performed title/abstract screening, full-text review and quality appraisal (using Newcastle Ottawa scale(NOS)/modified NOS); disagreements were resolved by a third reviewer. Data extraction focused on biomarker type, methodology, and population characteristics. RESULT: Thirty-four studies (27 cross-sectional; 7 longitudinal) were included, mostly evaluating Caucasian/White [n = 18], Asian [n = 15] and Mixed/Latin American [n = 1] populations. Consistent vascular diabetes biomarkers included wider arteriolar and venular calibers. Arteriolar narrowing predicted incident diabetes in longitudinal analyses. Increased vessel tortuosity and altered fractal dimension were frequently observed. Ethnic variation was more pronounced in longitudinal studies; AI-based research was largely confined to China. CONCLUSIONS: Retinal biomarkers show promise for early diabetes detection, but research remains geographically skewed and requires multiethnic validation to ensure clinical impact. These findings provide the biological ground truth necessary for handcrafted feature extraction in the development of interpretative artificial intelligence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersDiabetes Mellitus, Type 2Diabetic RetinopathyHumansCross-Sectional StudiesRisk FactorsPrognosis

Stichwörter der Autor:innen

Artificial intelligenceDiabetesOculomicsRetinal biomarkersSystematic scoping review

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Ophthalmology, Yenepoya (Deemed to be) University, Mangalore, India; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kin…
  • Department of Endocrinology, Yenepoya (Deemed to be) University, Mangalore, India; Center for Nutrition Studies, Yenepoya (Deemed to be) University, Mangalore, India.
  • Woodruff Health Sciences Center Library, Emory University, Atlanta, GA, USA.
  • Dr. Mohan's Diabetes Specialities Centre (IDF Centre of Excellence in Diabetes Care), Chennai, India; Dr. Rema Mohan Department of Ocular Research, Madras Diabetes Research Foundation, Chennai, India.
  • Emory Global Diabetes Research Center, Woodruff Health Sciences Center, And Emory University, Atlanta, GA, USA.
  • Dr. Mohan's Diabetes Specialities Centre (IDF Centre of Excellence in Diabetes Care), Chennai, India; Madras Diabetes Research Foundation (ICMR Collaborating Centre of Excellence), Chennai, India.

Förderung

  • FIC NIH HHS
  • BLRD VA
  • National Institutes of Health
  • National Institutes of Health Fogarty International Center

Zitieren

APA

Kaup, S., Bhat, S., Reardon, E. E., Prathiba, V., Rajalakshmi, R., Carrillo-Larco, R. M., Jagannathan, R., Anjana, R. M., Ali, M. K., Mohan, V., Kar, S. S., Madabhushi, A., Weber, M. B., & Venkat Narayan, K. M. (2026). Role of retinal biomarkers in diabetes detection and risk prediction: A systematic scoping review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 20(4), 103405. https://doi.org/10.1016/j.dsx.2026.103405

Vancouver

Kaup S, Bhat S, Reardon EE, Prathiba V, Rajalakshmi R, Carrillo-Larco RM, et al. Role of retinal biomarkers in diabetes detection and risk prediction: A systematic scoping review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2026;20(4):103405. doi:10.1016/j.dsx.2026.103405

BibTeX
@article{Kaup2026,
  author = {Kaup, Soujanya and Bhat, Sowrabha and Reardon, Erin E and Prathiba, Vijayaraghavan and Rajalakshmi, Ramachandran and Carrillo-Larco, Rodrigo M and Jagannathan, Ram and Anjana, Ranjit Mohan and Ali, Mohammed K and Mohan, Viswanathan and Kar, Sudeshna Sil and Madabhushi, Anant and Weber, Mary Beth and Venkat Narayan, K M},
  title = {Role of retinal biomarkers in diabetes detection and risk prediction: A systematic scoping review},
  journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
  year = {2026},
  volume = {20},
  number = {4},
  pages = {103405},
  doi = {10.1016/j.dsx.2026.103405}
}
Kostenlos starten →